HistoSonics secures $102m in blockbuster funding to transform liver cancer treatment forever
HistoSonics, a trailblazer in non-invasive histotripsy technology, has successfully concluded an oversubscribed $102 million Series D financing round. The round was spearheaded by Alpha Wave Ventures, a leading growth-stage investment firm, with substantial contributions from new investors Amzak Health and HealthQuest Capital. Existing investors also included Johnson & Johnson Innovation – JJDC, Inc. (JJDC), Venture […]